Shingles

Shingles can lay dormant in the human body after contracting chicken pox and become reactivated later in life.

Immunisation Coalition

About Shingles

Herpes zoster commonly known as shingles is caused by the same virus (varicella-zoster virus) responsible for chicken pox. After you have developed chickenpox, the virus lays dormant (inactive) in the body and can become reactivated later in life to cause shingles.

Shingles occurs mostly in people over 50 years of age. In most cases, it presents as a painful rash of small blisters which usually appears on one side of the face or body.

 

Shingles Symptoms

In 80% of cases, there is an early phase which occurs 2 to 3 days before the rash occurs.[1] These early symptoms may be severe pain, itching and numbness around the affected areas. The pain may be similar to the pain experienced from kidney stones, blocked blood vessels or inflammation of the gall bladder. This may be accompanied by headache, sensitivity to bright light or a general feeling of being unwell.

A blistery rash may follow which is often painful and lasts approximately 10-15 days.

Shingles can affect any part of the body but the rash typically appears as a band of blisters that wraps around the left or right side of the trunk of the body.

 

-----------

1 Dworkin RH,Johnson RW, Breuer J, et al. Recommendations for the management of herpes zoster. Clinical Infectious Diseases 2007; 44 Suppl 1: S1-26

How Shingles Spreads

Shingles cannot be passed from one person to another. However, a person with shingles can pass the varicella zoster virus to a person who has never had chicken pox or who has not had the chickenpox vaccine. In such cases, the person exposed to the virus may develop chickenpox but not shingles.[2][3]

The virus is spread by direct contact with the fluid contained in the blisters. Until the blisters scab over, the person is infectious. Avoid contact with people who have a weakened immune system, newborns and pregnant people while you are contagious.

In a national serosurvey conducted in 2007, more than 95% of the adult population in Australia had antibodies to Varicella-zoster virus by age 30, indicating that they had been previously infected with the virus.[4] Therefore almost the entire adult population is at risk of shingles.

Shingles is less contagious than chickenpox and the risk of a person with shingles spreading the virus is low if the rash is covered.

-----------

Centers for Disease Control and Prevention (CDC), https://www.cdc.gov/shingles/about/overview.html

Zoster vaccine for Australian adults/NCIRS Fact sheet: July 2021

Ward K, Dey A, Hull B, et al. Evaluation of Australia’s varicella vaccination program for children and adolescents. Vaccine 2013; 31:1413-9.

 

Shingles Complications

The most common complication is severe pain where the shingles rash was. The pain can interfere with you going about your everyday activities. This complication is known as post-herpetic neuralgia (PHN) which is defined as persistent chronic neuropathic pain (nerve pain) which persists for more than 90 days from the onset of the rash. PHN may be difficult to treat. As people get older, they are more likely to develop long term pain as a complication of shingles and the pain is likely to be more severe. In fact, PHN, affects 30% of people with shingles over 80 years of age.

Shingles may also lead to serious complications involving the eye called herpes zoster ophthalmicus (in about 10-20% of shingles patients.[5] Very rarely, shingles can lead to pneumonia, hearing problems, blindness, brain inflammation (encephalitis), or death.

-----------

5 Cunningham AL, Breuer J, Dwyer DE, et al. The prevention and management of herpes zoster, Medical Journal of Australia 2008; 188:171-6

Shingles Prevention

Preventing herpes zoster is the best way to avoid post-herpetic neuralgia and other complications. There are two zoster vaccines available in Australia Zostavax and Shingrix.

Shingrix

From 1 November 2023, the shingles vaccine Shingrix® will replace Zostavax® on the National Immunisation Program (NIP) schedule for the prevention of shingles and post-herpetic neuralgia. It will be available for eligible people most at risk of complications from shingles.

A 2-dose course of Shingrix® will be available for free for:

  • people aged 65 years and older
  • First Nations people aged 50 years and older
  • immunocompromised people aged 18 years and older with medical conditions including:
    • haemopoietic stem cell transplant
    • solid organ transplant
    • haematological malignancy
    • advanced or untreated HIV.

Unlike Zostavax®, Shingrix® does not contain any live virus so it can be given to people aged 18 years and over who are immunocompromised.

Zostavax® continues to be available on the NIP for immunocompetent people aged 70 years, with a catch-up program from 71–79 years, until 31 October 2023.

The program changes follow recommendations from the Pharmaceutical Benefits Advisory Committee, the Australian Technical Advisory Group on Immunisation (ATAGI) and other clinical experts.[6]

Shingles Treatment

Antiviral treatment may help to reduce pain and shorten the duration of shingles. The treatment is best taken within 72 hours of the onset of the rash but may still be helpful if taken after this time.

Page Published: 8 March 2017 | Page Updated: 20 August 2024